“Indians take Dolo 650 like it’s Cadbury Gems.”

That’s how a US-based gastroenterologist recently described India’s peculiar obsession with a single medicine called Dolo 650. Dolo became a household name during the COVID-19 pandemic and became the default medicine to fever, pain, or just general discomfort.

But here's the thing, Dolo is just paracetamol. And while it may be one of the most widely used over-the-counter drugs in the world, excessive and irresponsible use can cause serious harm.

What is Dolo 650?

Dolo 650 is a brand of paracetamol commonly used (and also prescribed) to treat fever and mild to moderate pain. It is manufactured by Micro Labs, a Bengaluru-based pharmaceutical company. While Dolo became synonymous with paracetamol in India—especially post-COVID—there are several other brands offering the same formulation. The drug is available in various forms: tablets, syrups, capsules, and even powder.

Why this dependence on Dolo?

There’s a strong belief among many Indians that "fever won’t go down unless I take Dolo." This perception grew during the pandemic when people hoarded the medicine and even now, Dolo continues to be the first line of defense for common ailments. But this blind faith comes with risks.

Overuse of Dolo (Paracetamol) and Its Dangers

Dr. Achintya Sharma, Max Hospital, warns against treating Dolo like a magic pill. “Dolo is just paracetamol. It’s a widely used, go-to drug, even during pregnancy. But overuse is a problem—it can affect the liver and kidneys. It should be used with caution.” He explains that taking Dolo too frequently, especially without medical consultation can lead to liver failure (especially if daily intake exceeds 4 grams), kidney issues, gastrointestinal side effects, like ulcers or GI bleeding (though rare). Paracetamol, similar to aspirin, can impact the digestive tract with prolonged or high-dose usage.

Who Should Be Extra Careful?

According to Dr. Sharma, certain groups should be extra cautious. Like children under 12 (especially with tablet form), people with pre-existing liver or kidney conditions, those with bleeding disorders or GI issues. In such cases, paracetamol should only be used after appropriate medical evaluation.

It's not just Dolo, it's a pattern. Dr. Suchismitha Rajamanya, Lead Consultant & HOD – Internal Medicine at Aster Whitefield Hospital, Bengaluru, highlights a broader concern. “Dolo has become synonymous with paracetamol. But it’s just one brand. Misuse and over-the-counter abuse of medications, even antibiotics like azithromycin are widespread.”

She adds that patients often self-medicate without understanding the root cause of their symptoms. “You can’t just pop a pill for every headache or fever. It may mask symptoms, but not treat the underlying issue.”

What About Alternatives?

Some people switch to Combiflam, a mix of paracetamol and ibuprofen, but that brings its own risks—more GI side effects, ulcers, and kidney concerns if taken over the long term. The main message is that no medicine is completely risk-free. Even commonly available drugs must be used judiciously and under proper guidance. The next time you feel under the weather, pause before popping a pill. Consult a doctor, understand what your body is telling you, and use medicines responsibly. Do not treat medicine like candy!

A team of US researchers has developed a novel nasal swab test, akin to those used to detect COVID-19 infections, which can spot early signs of Alzheimer's Disease -- affecting over 55 million people worldwide.

The condition is treatable in early stages to manage symptoms and slow cognitive decline. However, it remains the hardest to detect, affecting treatment outcomes. The brain changes can begin 10 to 20 years before symptoms become apparent.

The novel outpatient nasal swab, developed by Duke University researchers, has shown promise in picking up early biological changes linked to Alzheimer's. It can spot the degenerative condition, even before problems related to thinking and memory begin to appear.

"We want to be able to confirm Alzheimer's very early, before damage has a chance to build up in the brain," said Bradley J. Goldstein, professor at Duke University's School of Medicine.

"If we can diagnose people early enough, we might be able to start therapies that prevent them from ever developing clinical Alzheimer's," Goldstein added.

How Effective Was The Nasal Swab?

In the study, published in the journal Nature Communications, the team placed a gentle swab high inside the nose of 22 participants.

The swab collected thousands of nerve and immune cells to see which genes are active.

The analysis clearly differentiated people with early or diagnosed Alzheimer's from those without the disease -- 81 percent of the time. It also included people with no symptoms.

Alzheimer’s Disease: The Leading Cause of Dementia

Alzheimer's disease is one of the most common forms of dementia and mostly affects adults over the age of 65.

About 8.8 million Indians aged 60 and above are estimated to be living with Alzheimer's disease. Over seven million people in the US, 65 and older, live with the condition, and over 100,00 die from it annually.

Alzheimer's disease is believed to be caused by the development of toxic amyloid and beta proteins in the brain, which can accumulate and damage cells responsible for memory.

While there is no clear cause of Alzheimer's disease, experts believe it can develop due to genetic mutations and lifestyle choices, such as physical inactivity

unhealthy diet

social isolation.

Early symptoms of Alzheimer's disease include forgetting recent events or conversations. Other signs include:

• losing or misplacing things
• getting lost when walking or driving
• being confused, even in familiar places
• losing track of time
• difficulties solving problems or making decisions
• difficulties performing familiar tasks
• misjudging distances to objects visually.

Over time, Alzheimer's disease leads to serious memory loss and affects a person's ability to do everyday tasks.

Currently, there is no cure for this progressive brain disorder, and in advanced stages, loss of brain function can cause dehydration, poor nutrition, or infection. These complications can result in death.

Being physically active and taking part in activities and social interactions that stimulate the brain and maintain daily function can help prevent the condition.

The Human papillomavirus (HPV) vaccine is one of the most important advances in preventive healthcare, with the unique ability to prevent cancers.

Evidence consistently shows that the most appropriate age for HPV vaccination is between 9 and 14 years. At this stage, children develop a significantly stronger immune response, producing higher antibody titers than older adolescents and adults.

This enhanced immunogenicity translates into durable and highly effective protection and also allows simplified schedules, including the possibility of single-dose protection, thereby improving feasibility and coverage at a population level.

HPV Vaccine: Why Age 14 Matters The Most

The emphasis on vaccination by the age of 14 years is particularly important. Beyond this age, the immune response is relatively lower, and the number of doses required increases, making early vaccination both scientifically and programmatically more efficient.

Recognizing this, the Government of India has adopted a strategy of administering a single-dose HPV vaccine to adolescents up to 14 years of age through school- and community-based outreach programs. The program utilizes the Gardasil vaccine, which has an established track record of safety and efficacy over nearly two decades.

Equally critical is the timing of vaccination in relation to exposure. HPV is primarily transmitted through sexual contact, and vaccination before exposure ensures maximum effectiveness. Administering the vaccine in early adolescence provides protection well before any potential risk, making it a true preventive intervention with near-complete benefit.

Persistent infection with high-risk HPV types is a well-established cause of several cancers. In India, cervical cancer continues to be one of the leading causes of cancer-related illness and death among women. While HPV is also responsible for anal, penile, and oropharyngeal cancers, the burden of cervical cancer is substantially higher, which has historically led to a greater focus on vaccinating girls.

HPV: Are Boys At Risk?

However, HPV infection affects both genders. Boys are also at risk of HPV-related diseases, including anal and penile cancers, genital warts, and oropharyngeal cancers, the incidence of which is rising globally.

Vaccinating boys offers direct protection to them and also contributes to reducing transmission within the community. A broader, gender-inclusive approach has the potential to enhance population-level protection.

Public health agencies, including the World Health Organization, have emphasized HPV vaccination as a key strategy in cancer prevention and in reducing the long-term burden of non-communicable diseases.

HPV Vaccine: Part of Adolescent Health Check-ups

Integrating HPV vaccination into routine adolescent health check-ups can further normalize it as a standard preventive health measure. This approach can complement government efforts by encouraging participation from the private healthcare sector and improving overall uptake.

HPV vaccination in the 9–14 year age group is therefore not merely a recommendation; it is a time-sensitive, evidence-based intervention that can prevent cancers decades later. Strengthening awareness and ensuring timely vaccination will be critical in reducing the future burden of HPV-related cancers in India.

Heart diseases are viewed as a universal health concern, and advancements in cardiology have hugely improved diagnosis and treatment outcomes around the world. At the same time, emerging research is shedding more light on how cardiovascular disease affects women.

In India, this perspective is especially important. Of the more than 10 million deaths recorded annually in the country, nearly two million are attributed to diseases of the circulatory system, with women accounting for about 40% of these cases. Significantly, more than half of the nearly 800,000 cardiovascular deaths among Indian women each year occur prematurely, underscoring the importance of greater awareness, early detection, and timely medical care.

How Cardiac Research Has Evolved

It is evident that modern cardiology has been shaped by the findings from large, well-characterized populations of patients. The frameworks that have been established from such findings are the ones that guide the approaches that are currently used in the diagnosis and treatment of various forms of heart disease.

Such frameworks have been instrumental in the advancement of the management of various forms of cardiovascular diseases worldwide. As the research expands to include larger populations, there is an increased understanding that the manifestation of cardiovascular diseases differs from one group to another, particularly in females.

Recognizing Differences In Symptoms

This growing awareness is particularly useful in recognizing symptoms. Although women, like men, may experience chest pain as a symptom of a heart attack, there are other, less common symptoms that women may also experience.

These include fatigue, shortness of breath, nausea, dizziness, as well as neck, jaw, or back discomfort. The awareness of these symptoms will allow women to seek treatment sooner, as well as help healthcare providers better understand their symptoms.

The Role of Life Stages in Women’s Heart Health

Women’s heart health is influenced by various life stages and the hormonal changes that accompany them. For instance, after menopause, estrogen levels decline, and since this hormone offers some protective benefits for the heart, the risk of developing heart disease may gradually rise.

Certain pregnancy-related conditions, including gestational diabetes, preeclampsia, and high blood pressure during pregnancy, may also indicate a greater likelihood of cardiovascular disease later in life. Recognising these factors allows doctors to monitor heart health more closely and recommend preventive measures that support long-term wellbeing.

Strengthening Prevention And Early Detection

Prevention continues to be one of the most effective strategies for reducing heart disease. Regular health check-ups, along with monitoring blood pressure, cholesterol, and blood sugar, are essential for lowering cardiovascular risk. Adopting healthy lifestyle habits further supports long-term heart health. Awareness is equally important.

Symptoms such as fatigue or breathlessness are not always immediately linked to heart disease, particularly among women. Raising awareness about heart health can help people recognize early warning signs sooner and seek timely care.

Moving Toward More Inclusive Cardiac Care

Encouragingly, the field of cardiology is constantly evolving with the help of emerging research that is further enlightening us about the health of the heart in both men and women. With more women being included in research and better developments in diagnostic procedures, healthcare professionals are refining their strategies to deal with heart health.

Thus, by adopting the best strategies and emerging research about the health of women’s hearts, awareness and early intervention are the keys to better outcomes and reduced risks among women in India.